Biologics Safety Testing Market Growing at 12.5% CAGR

Delvens08 Feb, 2022Business

An increased RnD in biopharmaceutical sector along with raising concerns over cell contamination and growth of the market of biosimilar and biologics are some of the factors that have supported long-term expansion for Biologics Safety Testing industry. As per Delvens' market analysis report, Global Biologics Safety Testing market is anticipated to grow at a CAGR of 12.5% during the forecasting period, 2021-2028.